Skip to main content

Search Results for

“电报会员价格👉【SMMFS.COM】刷粉渠道电报会员,rap”

October 23, 2018

Denosumab (Prolia) has been shown to reduce the risk of fracture in postmenopausal women and men ≥50 years old with osteoporosis. It has also been approved for steroid induced bone […]

December 7, 2023

Peace Arch Hospital, BC Peace Arch Hospital, BC Establishment of A FLS Training and Mentorship Program for the Peace Arch Hospital in B.C. Establishment of A FLS Training and Mentorship […]

October 23, 2018

Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

July 2, 2024


April 8, 2019

BONE MINERAL DENSITY TEST A BMD test can tell you whether or not you have osteoporosis Why Should I Get Tested? A risk factor assessment is an important first step […]

April 8, 2019

Frequently Asked Questions What causes osteoporosis? No single cause for osteoporosis has been identified. However, certain factors – called risk factors – do seem to play a role in the […]

June 7, 2019

Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

June 15, 2012

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

May 25, 2020

Important Changes to the Availability and Conditions of Use for Drugs Containing Calcitonin Calcitonin nasal spray for the treatment of osteoporosis is no longer available in Canada because of new […]

© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001